(Q51829598)
Statements
Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors. (English)
1 reference
Valérie Vantomme
1 reference
Christine Dantinne
1 reference
Noreddine Amrani
1 reference
Philippe Permanne
1 reference
Dirk Gheysen
1 reference
Claudine Bruck
1 reference
Gerrit Stoter
1 reference
Cedrik M Britten
1 reference
Ulrich Keilholz
1 reference
Cor H J Lamers
1 reference
Marie Marchand
1 reference
Marcel Delire
1 reference
Maryse Guéguen
1 reference
1 March 2004
1 reference
27
1 reference
2
1 reference
124-135
1 reference